The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Cancer-Secreted miR-105 Destroys Vascular Endothelial Barriers to Promote Metastasis
Open accessAbstract
Cancer-secreted microRNAs (miRNAs) are emerging mediators of cancer-host crosstalk. Here we show that miR-105, which is characteristically expressed and secreted by metastatic breast cancer cells, is a potent regulator of migration through targeting the tight junction protein ZO-1. In endothelial monolayers, exosome-mediated transfer of cancer-secreted miR-105 efficiently destroys tight junctions and the integrity of these natural barriers against metastasis. Overexpression of miR-105 in nonmetastatic cancer cells induces metastasis and vascular permeability in distant organs, whereas inhibition of miR-105 in highly metastatic tumors alleviates these effects. miR-105 can be detected in the circulation at the premetastatic stage, and its levels in the blood and tumor are associated with ZO-1 expression and metastatic progression in early-stage breast cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Many studies have also demonstrated that extracellular miRNAs can exert biological functions in recipient cells to regulate their activity, thereby acting as intercellular signaling molecules.”
From Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation (2018) · cites this paper as [134]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer
Taylor, D. D., & Gerçel-Taylor, Ç. (2008) · Gynecologic Oncology · doi:10.1016/j.ygyno.2008.04.033 · Cited by 2,333
RetractedValadi, H., Ekström, K., Bossios, A., Sjöstrand, M., Lee, J. J., & Lötvall, J. O. (2007) · Nature Cell Biology · doi:10.1038/ncb1596 · Cited by 12,834
Circulating microRNAs as stable blood-based markers for cancer detection
Mitchell, P. S., Parkin, R. K., Kroh, E. M., Fritz, B. R., Wyman, S. K., Pogosova-Agadjanyan, E. L., Peterson, A., Noteboom, J., O'Briant, K. C., Allen, A., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804549105 · Cited by 7,969
MicroRNA signatures in human cancers
Calin, G. A., & Croce, C. M. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1997 · Cited by 7,668
Isolation and Characterization of Exosomes from Cell Culture Supernatants and Biological Fluids
Théry, C., Amigorena, S., Raposo, G., & Clayton, A. (2006) · Current Protocols in Cell Biology · doi:10.1002/0471143030.cb0322s30 · Cited by 5,766
Exosomes: composition, biogenesis and function
Théry, C., Zitvogel, L., & Amigorena, S. (2002) · Nature reviews. Immunology · doi:10.1038/nri855 · Cited by 5,478
The distribution of secondary growths in cancer of the breast.
Paget, S. (1889) · The Lancet · doi:10.1016/s0140-6736(00)49915-0 · Cited by 5,277
Skog, J., Würdinger, T., van Rijn, S., Meijer, D. H., Gainche, L., Curry, W. T., Carter, B. S., Krichevsky, A. M., & Breakefield, X. O. (2008) · Nature Cell Biology · doi:10.1038/ncb1800 · Cited by 5,001
MicroRNA Gene Expression Deregulation in Human Breast Cancer
Iorio, M. V., Ferracin, M., Liu, C.-G., Veronese, A., Spizzo, R., Sabbioni, S., Magri, E., Pedriali, M., Fabbri, M., Campiglio, M., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1783 · Cited by 4,053
Dissemination and growth of cancer cells in metastatic sites
Chambers, A. F., Groom, A. C., & MacDonald, I. C. (2002) · Nature reviews. Cancer · doi:10.1038/nrc865 · Cited by 4,018
Cited by
Sorted by citations
Items 901–1,000 of 1,001
Extracellular vesicle-mediated drug delivery in breast cancer theranostics
Abdul‐Rahman, T., Roy, P., Herrera‐Calderón, R. E., Khidri, F. F., Omotesho, Q. A., Rumide, T. S., Fatima, M., Roy, S., Awuah, W. A., Atallah, O., et al. (2024) · Discover Oncology · doi:10.1007/s12672-024-01007-y · Cited by 17
“Furthermore, exosome-mediated delivery of tumor-secreted miR-105 selectively destroys tight junctions and the integrity of natural barriers, enhancing metastasis in BC [114].”
BackgroundNouraee, N., Mowla, S. J., & Călin, G. A. (2015) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22244 · Cited by 18
Exosome‑mediated peritoneal dissemination in gastric cancer and its clinical applications (Review)
Chen, K., Chen, J., Jin, X., Huang, Y., Su, Q., & Chen, L. (2018) · Biomedical Reports · doi:10.3892/br.2018.1088 · Cited by 17
“Serum exosomal miRNA-105 levels were observed to increase in breast cancer patients upon development of metastatic disease (45).”
Lewis, D. M., Mavrogiannis, N., Gagnon, Z. R., & Gerecht, S. (2018) · Biomicrofluidics · doi:10.1063/1.5026901 · Cited by 18
Wang, S., Wang, J., Wei, W., & Ma, G. (2019) · Advanced Biosystems · doi:10.1002/adbi.201900008 · Cited by 17
A miRNA signature in endothelial cell-derived extracellular vesicles in tumor-bearing mice
McCann, J. V., Liu, A., Musante, L., Erdbrügger, U., Lannigan, J. A., & Dudley, A. C. (2019) · Scientific Reports · doi:10.1038/s41598-019-52466-1 · Cited by 17
Mantile, F., Franco, P., Stoppelli, M. P., & Liguori, G. L. (2020) · Advances in biomembranes and lipid self-assembly · doi:10.1016/bs.abl.2020.05.006 · Cited by 22
Engin, A. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-49844-3_4 · Cited by 18
Harnessing EV communication to restore antitumor immunity
Massaro, C., Min, W., Pegtel, D. M., & Baglio, S. R. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113838 · Cited by 17
Regulation of miRNAs Expression by Mutant p53 Gain of Function in Cancer
Madrigal, T., Hernández‐Monge, J., Herrera, L. A., la Rosa, C. H. G.-D., Domínguez-Gómez, G., Candelaria, M., Luna-Maldonado, F., Calderón-González, K. G., & Díaz‐Chávez, J. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.695723 · Cited by 18
Chen, H., Zeng, B., Li, X.-S., Zhao, Q., Liu, D.-D., Chen, Y.-T., Zhang, Y., Wang, J., & Xing, H. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.895164 · Cited by 17
Singhal, A., Agrawal, A., & Ling, J. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13553 · Cited by 17
Zhou, Y., Xia, Z., Cheng, Z., Xu, G., Yang, X., Liu, S., & Zhu, Y. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.005057 · Cited by 17
Li, T., Li, T., Liang, Y., Yuan, Y., Liu, Y., Yao, Y., & Lei, X. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06334-4 · Cited by 16
“Exosome-mediated transfer of cancer-secreted miR-105 efficiently destroys tight junctions by targeting ZO-1 to promote breast cancer metastasis [54]. miR-188-3p has been reported as a cancer-promoting miRNA that correlated with poor prognosis of CRC patients [35].”
Platelet Extracellular Vesicles as Natural Delivery Vehicles for Mitochondrial Dysfunction Therapy?
Yeh, H. C., Gupta, K., Lu, Y.-H., Srinivasan, A., Delila, L., Yen, N. T. H., Nyam‐Erdene, A., & Burnouf, T. (2025) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.5c00473 · Cited by 17
Su, G., Qian, J., Wang, Y., Zhu, Y., Chen, Y., Shen, J., Jiang, J., Cao, Y., Wang, N., Huang, X., et al. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07914-4 · Cited by 16
Exosomal regulation of cellular reprogramming and polarization in the tumor microenvironment
Bayat, M., Shahabi, P., Rezaei, T., & Nahand, J. S. (2025) · Cancer Cell International · doi:10.1186/s12935-025-04105-1 · Cited by 17
“…such as miR-455 from hypoxic nasopharyngeal carcinoma cells [277], miR-23a, originating from lung cancer [278], miR-105, derived from metastatic breast cancer cells [279], have been shown to promote increased permeability of endothelial cells by negatively regulating tight junction protein ZO-1.”
Jin, Y., Zhang, Y., Song, M., Zhou, J., Zhang, H., & Ding, Y. (2026) · Cell Biomaterials · doi:10.1016/j.celbio.2025.100344 · Cited by 17
Recent advances in melanoma research via “omics” platforms
Rodríguez‐Cerdeira, C., Molares-Vila, A., Carnero-Gregorio, M., & Corbalán-Rivas, A. (2017) · Journal of Proteomics · doi:10.1016/j.jprot.2017.11.005 · Cited by 16
The role of tumor-derived exosomes in tumor angiogenesis and tumor progression
Głuszko, A., Mirza, S. M., Piszczatowska, K., Kantor, I., Struga, M., & Szczepański, M. J. (2019) · Current Issues in Pharmacy and Medical Sciences · doi:10.2478/cipms-2019-0034 · Cited by 16
MiR-22-3p Suppresses Cell Migration and Invasion by Targeting PLAGL2 in Breast Cancer
Fan, T., Wang, C., Li, X., Yang, H., Zhou, J., & Song, Y. (2021) · Journal of College of Physicians And Surgeons Pakistan · doi:10.29271/jcpsp.2021.08.937 · Cited by 16
Tong, Y., Bao, C., Xu, Y.-Q., Tao, L., Zhou, Y., Zhuang, L., Meng, Y., Zhang, H., Xue, J., Wang, W., et al. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s331939 · Cited by 17
Nanomedicine for targeting the lung cancer cells by interpreting the signaling pathways
Habeeb, M., Kareem, T. A., Deepthi, K. L., Khot, V. S., Woon, Y. H., & Pawar, S. S. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2022.103865 · Cited by 17
Relationship between exosomes and cancer: formation, diagnosis, and treatment
Huang, C., Li, J., Xie, Z., Hu, X., & Huang, Y. (2024) · International Journal of Biological Sciences · doi:10.7150/ijbs.95763 · Cited by 19
ITRAQ-Based Proteomics Analysis of Acute Lung Injury Induced by Oleic Acid in Mice
Xu, X., Zhu, Q., Zhang, R., Wang, Y., Niu, F., Wang, W., Sun, D., & Wang, A. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000485885 · Cited by 16
Kang, L., Shen, L., Lu, L., Wang, D., Zhao, Y. M., Chen, C., Du, L., Gong, J., Zhang, Y., Mi, X., et al. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.05.003 · Cited by 16
MicroRNAs Patterns as Potential Tools for Diagnostic and Prognostic Follow-Up in Cancer Survivorship
Conti, I., Simioni, C., Varano, G., Brenna, C., Costanzi, E., & Neri, L. M. (2021) · Cells · doi:10.3390/cells10082069 · Cited by 16
The Potential Role of Exosomes in the Treatment of Brain Tumors, Recent Updates and Advances
Huang, Z., Keramat, S., Izadirad, M., Chen, Z., & Soukhtanloo, M. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.869929 · Cited by 16
Wu, F., Yang, J., Shang, G., Zhang, Z., Niu, S., Liu, Y., Liu, H., Jing, J., & Yu, F. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/5983629 · Cited by 16
“Meanwhile, cancer cell-derived miRNAs can be delivered to recipient cells via exosomes, then perform a key regulatory role in migration and invasion of CRC cells [18, 19].”
Wu, A., Wolley, M. J., Fenton, R. A., & Stowasser, M. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.981317 · Cited by 16
Extracellular Vesicles in Cancer: Mechanistic Insights and Clinical Applications
Alhumaydhi, F. A., & Anwar, S. (2026) · Cancers · doi:10.3390/cancers18030537 · Cited by 16
Living Proof of Activity of Extracellular Vesicles in the Central Nervous System
Mahjoum, S., Rufino‐Ramos, D., de Almeida, L. P., Broekman, M. L. D., Breakefield, X. O., & van Solinge, T. S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147294 · Cited by 14
Exosomes in Age-Related Cognitive Decline: Mechanistic Insights and Improving Outcomes
Duggan, M. R., Lu, A., Foster, T. C., Wimmer, M. E., & Parikh, V. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.834775 · Cited by 15
Duréndez-Saéz, E., Fariñas, S. C., Torres‐Martínez, S., Moreno‐Manuel, A., Herreros‐Pomares, A., Escorihuela, E., Mosqueda, M., Gallach, S., Guijarro, R., Serna, E., et al. (2022) · Cancers · doi:10.3390/cancers14133216 · Cited by 15
Extracellular vesicle-mediated immunoregulation in cancer
Yamamoto, T., Yamamoto, Y., & Ochiya, T. (2022) · International Journal of Hematology · doi:10.1007/s12185-022-03436-3 · Cited by 15
Extracellular vesicles in vaccine development and therapeutic approaches for viral diseases
Pordanjani, P. M., Bolhassani, A., Milani, A., & Pouriayevali, M. H. (2023) · Process Biochemistry · doi:10.1016/j.procbio.2023.02.028 · Cited by 15
Cheng, J., Zhang, K., Qu, C., Peng, J., & Yang, L. (2023) · Cancers · doi:10.3390/cancers15072158 · Cited by 15
Prediction of miRNA–Disease Associations by Cascade Forest Model Based on Stacked Autoencoder
Hu, X., Yin, Z., Zeng, Z., & Peng, Y. (2023) · Molecules · doi:10.3390/molecules28135013 · Cited by 15
3D spheroid-microvasculature-on-a-chip for tumor-endothelium mechanobiology interplay
Zhang, Y., Jiang, F., Zhao, Y. C., Cho, A., Fang, G., Cox, C. D., Zreiqat, H., Lu, Z. F., Lu, H., & Ju, L. A. (2023) · Biomedical Materials · doi:10.1088/1748-605x/ace7a4 · Cited by 15
Morimoto, M., Maishi, N., & Hida, K. (2024) · Cancer Drug Resistance · doi:10.20517/cdr.2023.121 · Cited by 16
Zhongyu, X., Xu, W., Hongmei, Z., Xiaodong, G., Xiaojing, Y., Yuanpei, L., Zhu, L., Zhenmin, F., & Xu, J. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117203 · Cited by 16
Vatter, F. A. P., Lucotti, S., & Zhang, H. (2020) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-020-09473-0 · Cited by 16
Li, D., Lai, W., Wang, Q., Xiang, Z., Nan, X., Yang, X., & Fang, Q. (2021) · Biochimie · doi:10.1016/j.biochi.2021.06.007 · Cited by 15
Mallick, A. M., Biswas, A., Mishra, S., Jadhav, S., Chakraborty, K., Tripathi, A., Mukherjee, A., & Roy, R. S. (2023) · Chemical Science · doi:10.1039/d3sc01071f · Cited by 15
Joint testing and false discovery rate control in high-dimensional multivariate regression
Yin, X., Cai, T., & Li, H. (2017) · Biometrika · doi:10.1093/biomet/asx085 · Cited by 15
Yang, Y., Chen, C. O., Lyu, Y., Gololobova, O. A., Guo, X., Huang, T. Y.-T., Ramu, V. K., Talwar, V., Wicks, E. E., Salman, S., et al. (2025) · Journal of Clinical Investigation · doi:10.1172/jci190470 · Cited by 16
“…selection of BC cells with increased tropism to the brain (14, 16–18), the identification of specific genes and signaling pathways that promote (15–17, 19– 22) or suppress ( Brain metastasis is a major cause of breast cancer (BC) mortality, but the cellular and molecular mechanisms have not…”
Tian, J., Liu, M., Yang, X., Wang, T., Zhou, R., Liu, J., Ma, B., Su, C., & Duan, X. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.146489 · Cited by 14
Saha, P., Datta, S., Ghosh, S., Samanta, A., Ghosh, P., & Sinha, D. (2021) · Bioengineering · doi:10.3390/bioengineering8100139 · Cited by 15
Aili, Y., Maimaitiming, N., Hu, Q., Ji, W., Fan, G., Wang, Z., & Wang, Y. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.983878 · Cited by 14
Pontis, F., Roz, L., Fortunato, O., & Bertolini, G. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1116783 · Cited by 15
Duan, S., Fu, W.-J., Jiang, Y.-K., Peng, L., Ousmane, D., Zhang, Z., & Wang, J. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1220193 · Cited by 16
ExoPD-L1: an assistant for tumor progression and potential diagnostic marker
Hu, R. H., Jahan, M. S., & Tang, L. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1194180 · Cited by 14
Non-Coding RNAs as Potential Diagnostic/Prognostic Markers for Hepatocellular Carcinoma
Tonon, F., Grassi, C., Tierno, D., Biasin, A., Grassi, M., Grassi, G., & Dapas, B. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252212235 · Cited by 16
“…enhancing chemo-resistance and attenuating the cell apoptosis induced by cisplatin in cisplatin-sensitive ovarian cancer cells [92]. miR-105-1 has been previously identified as a key regulator of circulation, the pre-metastatic process, and metastatic progression in early breast cancer [93].”
LeBlanc, V., & Morin, P. (2015) · Journal of Clinical Medicine · doi:10.3390/jcm4081612 · Cited by 13
Gómez-Cambronero, J. (2018) · Cancer and Metastasis Reviews · doi:10.1007/s10555-018-9753-x · Cited by 15
Ishii, K., Yamashita, H., Yamaguchi, M., Komatsu, Y., Ryu, E., Morishita, S., Matsuo, K., Kamada, M., Ikeda, T., Ashizawa, K., et al. (2019) · Internal Medicine · doi:10.2169/internalmedicine.3098-19 · Cited by 14
Tiny Actors in the Big Cellular World: Extracellular Vesicles Playing Critical Roles in Cancer
Jurj, A. M., Bica, C., Slabý, O., Stefan, D. C., Cho, W. C. S., Korban, S. S., & Berindan‐Neagoe, I. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207688 · Cited by 14
miR-519d-3p suppresses tumorigenicity and metastasis by inhibiting Bcl-w and HIF-1α in NSCLC
Choi, J. Y., Seok, H. J., Kim, R.-K., Choi, M. Y., Lee, S., & Bae, I. H. (2021) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2021.06.015 · Cited by 14
Han, F., Yang, B., Zhou, M., Huang, Q., Mai, M., Huang, Z., Lai, M., Xu, E., & Zhang, H. (2022) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjac009 · Cited by 14
The Significance of MicroRNAs in the Molecular Pathology of Brain Metastases
Siegl, F., Večeřa, M., Rošková, I., Smrčka, M., Jančálek, R., Kazda, T., Slabý, O., & Šáňa, J. (2022) · Cancers · doi:10.3390/cancers14143386 · Cited by 15
Gherman, A., Bălăcescu, L., Popa, C., Cainap, C. I., Vlad, C. I., Cainap, S. S., & Bălăcescu, O. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310622 · Cited by 14
Battistella, M., & Marsden, P. A. (2015) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.8 · Cited by 15
The Exosome And Breast Cancer Cell Plasticity
Mao, X., & Jin, F. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s214133 · Cited by 14
Extracellular Vesicles in Tumors: A Potential Mediator of Bone Metastasis
Li, S., & Wang, W. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.639514 · Cited by 14
Zhou, H., Zheng, D., Wang, H., Wu, Y., Peng, X., Li, Q., Li, T., & Liu, L. (2021) · Cell Communication and Signaling · doi:10.1186/s12964-021-00795-y · Cited by 14
Circulating microRNA trafficking and regulation: computational principles and practice
Cui, J., & Shu, J. (2019) · Briefings in Bioinformatics · doi:10.1093/bib/bbz079 · Cited by 13
“For example, exosomal miRNAs from cancer cell promote tumor growth in distant tissues, e.g. miR-105 from breast cancer to lung, brain and other tissues [37–42] and adipose tissue-specific exosomal miRNAs regulate metabolic function in distant tissues [21, 43].”
BackgroundShin, Y., Choi, H. Y., Kwak, Y., Yang, G., Jeong, Y., Jeon, T.-I., Seok, J., Lee, E.-R., Kim, J., Jeon, K., et al. (2023) · Journal of Cancer · doi:10.7150/jca.81600 · Cited by 13
“For example, it has been shown that overexpression or inhibition of miRNA in breast cancer is associated with the development and progression of breast cancer [30, 31].”
BackgroundMorimoto, M., Maishi, N., Tsumita, T., Alam, M. T., Kikuchi, H., Hida, Y., Yoshioka, Y., Ochiya, T., Annan, D. A., Takeda, R., et al. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.973871 · Cited by 13
The Role of MicroRNAs in Uterine Leiomyosarcoma Diagnosis and Treatment
Psilopatis, I., Vrettou, K., Kokkali, S., & Theocharis, S. E. (2023) · Cancers · doi:10.3390/cancers15092420 · Cited by 13
Emerging role of mesenchymal stem cells-derived extracellular vesicles in vascular dementia
Liu, Z., Cheng, L., Zhang, L., Shen, C., Wei, S., Wang, L., Qiu, Y., Li, C., Xiong, Y., & Zhang, X. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1329357 · Cited by 15
Khoushab, S., Aghmiuni, M. H., Esfandiari, N., Sarvandani, M. R. R., Rashidi, M., Taheriazam, A., Entezari, M., & Hashemi, M. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2024.155214 · Cited by 14
COL6A3 Exosomes Promote Tumor Dissemination and Metastasis in Epithelial Ovarian Cancer
Ho, C., Yen, T., Chang, T., & Huang, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25158121 · Cited by 15
Engineering extracellular vesicles to transiently permeabilize the blood–brain barrier
Tomatis, F., Rosa, S. C., Simões, S. M. N., Barão, M., Jesus, C., Novo, J. P., Barth, E., Marz, M., & Ferreira, L. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-03019-w · Cited by 13
Alghazali, T. A. H., Ahmed, A. T., Hussein, U. A., Sanghvi, G. V., Uthirapathy, S., Edan, R. T., Lal, M., Shit, D., Naidu, K. S., & AL-Hamairy, A. K. (2025) · Medical Oncology · doi:10.1007/s12032-025-02690-9 · Cited by 13
“Breast cancer cells that have spread metastatically express miR-105 strongly [99].”
Pathological Features of Brain Metastases
Tadros, S., & Ray‐Chaudhury, A. (2020) · Neurosurgery Clinics of North America · doi:10.1016/j.nec.2020.06.005 · Cited by 14
Exosomal microRNAs: Pleiotropic Impacts on Breast Cancer Metastasis and Their Clinical Perspectives
Tang, L.-B., Ma, S.-X., Chen, Z., Huang, Q.-Y., Wu, L., Wang, Y., Zhao, R., & Xiong, L. (2021) · Biology · doi:10.3390/biology10040307 · Cited by 13
A fatal affair: Circulating tumor cell relationships that shape metastasis
Ozimski, L. L., Gremmelspacher, D., & Aceto, N. (2021) · iScience · doi:10.1016/j.isci.2021.103073 · Cited by 13
BAT Exosomes: Metabolic Crosstalk with Other Organs and Biomarkers for BAT Activity
Goody, D., & Pfeifer, A. (2018) · Handbook of experimental pharmacology · doi:10.1007/164_2018_114 · Cited by 13
Flamini, V., Dudley, E., Jiang, W. G., & Cui, Y. (2018) · Oncotarget · doi:10.18632/oncotarget.26356 · Cited by 13
Deen, N. N. A., Nassar, F. J., Nasr, R., & Talhouk, R. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-20301-6_18 · Cited by 13
miRNAs: Critical mediators of breast cancer metastatic programming
Nair, M. G., Somashekaraiah, V. M., Ramamurthy, V., Prabhu, J. S., & Sridhar, T. S. (2021) · Experimental Cell Research · doi:10.1016/j.yexcr.2021.112518 · Cited by 15
MARATOVICH, B. A., Al-Yozbaki, M., Ashirbekov, Y., Satken, K., Abaildayev, A., Yeleussizov, A., Jainakbayev, N. T., Sharipov, K. O., & Wilson, C. M. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1676530 · Cited by 12
Exosomes and MicroRNAs in Biomedical Science
Mirzaei, H., Rahimian, N., Mirzaei, H. R., Nahand, J. S., & Hamblin, M. R. (2022) · Synthesis lectures on biomedical engineering · doi:10.2200/s01171ed1v01y202202bme062 · Cited by 27
The Roles of Exosomes in Metastasis of Sarcoma: From Biomarkers to Therapeutic Targets
Tan, L., Wang, Y., Hu, X., & Min, L. (2023) · Biomolecules · doi:10.3390/biom13030456 · Cited by 12
Luo, J., Wang, Z., Zhang, X., Yu, H., Chen, H., Song, K., Zhang, Y., Schwartz, L. M., Chen, H., Liu, Y., et al. (2023) · Cancers · doi:10.3390/cancers15174257 · Cited by 12
Berti, F. C. B., Tofolo, M. V., Nunes-Souza, E., Marchi, R., Okano, L. M., Ruthes, M. O., Rosolen, D., Malheiros, D., Fonseca, A. S., & Cavalli, L. R. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.122332 · Cited by 11
Influence of Breast Cancer Extracellular Vesicles on Immune Cell Activation: A Pilot Study
Santoro, J., Carrese, B., Peluso, M. S., Coppola, L., D’Aiuto, M., Mossetti, G., Salvatore, M., & Smaldone, G. (2023) · Biology · doi:10.3390/biology12121531 · Cited by 12
“These particles can promote tumor invasion and metastasis through the modification of epithelial cells and induction of epithelial–mesenchymal transition (EMT) [18–20].”
BackgroundPetrova, T., Kalinina, O., Aquino, A. D., Grigoryev, E. A., Dubashynskaya, N. V., Zubkova, K. D., Kostareva, A. A., & Головкин, А. С. (2024) · Non-Coding RNA · doi:10.3390/ncrna10010015 · Cited by 14
“For instance, miRNA 105, secreted in breast cancer cell exosomes, disrupts epithelial monolayer tight junctions, promoting metastasis [21].”
BackgroundEvolving insights into erythrocytes in synucleinopathies
Yang, Y., Nie, X., Wang, Y., Sun, J., Gao, X., & Zhang, J. (2024) · Trends in Neurosciences · doi:10.1016/j.tins.2024.06.005 · Cited by 14
Han, M., Zhou, X., Cheng, H., Qiu, M., Qiao, M., & Geng, X. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.138800 · Cited by 14
Vitale, A. M., Santonocito, R., Vergilio, G., Marino, A., Campanella, C., de Macario, E. C., Bucchieri, F., Macario, A. J. L., & Bavisotto, C. C. (2020) · Applied Sciences · doi:10.3390/app10196961 · Cited by 13
Breast Cancer Microenvironment Cross Talk through Extracellular Vesicle RNAs
Dogra, S., & Hannafon, B. N. (2021) · American Journal Of Pathology · doi:10.1016/j.ajpath.2021.03.014 · Cited by 11
Bhattacharjee, R., Mitra, P., Gupta, N., Sharma, S., Singh, V. K., Mukerjee, N., Dhasmana, A., & Gundamaraju, R. (2022) · Advances in Cancer Biology - Metastasis · doi:10.1016/j.adcanc.2022.100050 · Cited by 12
The cellular and molecular mediators of metastasis to the lung
Cucanic, O., Farnsworth, R. H., & Stacker, S. A. (2022) · Growth Factors · doi:10.1080/08977194.2022.2087520 · Cited by 13
Christenson, J. L., Williams, M. M., & Richer, J. K. (2022) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00181.2022 · Cited by 12
Gu, Z., Yin, H., Zhang, H., Zhang, H., Liu, X., Zeng, X., & Zheng, X. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.956167 · Cited by 12
MiRNAs and snoRNAs in Bone Metastasis: Functional Roles and Clinical Potential
Puppo, M., Jaafar, M., Diaz, J., Marcel, V., & Clézardin, P. (2022) · Cancers · doi:10.3390/cancers15010242 · Cited by 14
Applications of Exosome Vesicles in Different Cancer Types as Biomarkers
Ihlamur, M., Kelleci, K., Zengin, Y., Allahverdiyev, A., & Abamor, E. Ş. (2023) · Current Molecular Medicine · doi:10.2174/1566524023666230320120419 · Cited by 13
Kimoto, A., Kadoi, Y., Tsuruda, T., Kim, Y., Miyoshi, M., Nomoto, Y., Nakata, Y., Miyake, M., Miyashita, K., Shimizu, K., et al. (2023) · Pancreatology · doi:10.1016/j.pan.2023.04.002 · Cited by 12
CFNCM: Collaborative filtering neighborhood-based model for predicting miRNA-disease associations
Momanyi, B. M., Zulfiqar, H., Grace-Mercure, B. K., Ahmed, Z., Ding, H., Gao, H., & Liu, F. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.107165 · Cited by 13
Metadata
- Authors
- Zhou, W., Fong, M. Y., Min, Y., Somlo, G., Liu, L., Palomares, M. R., Yu, Y., Chow, A., O’Connor, S. T. F., Chin, A. R., Yen, Y., Wang, Y., Marcusson, E. G., Chu, P., Wu, J., Wu, X., Li, A. X., Li, Z., Gao, H., Ren, X., Boldin, M. P., Lin, P. C., & Wang, S. E.
- Affiliations
- City Of Hope National Medical Center (US)
- National Cancer Institute (US)
- Regulus Therapeutics (United States) (US)
- Tianjin Medical University Cancer Institute and Hospital (CN)
- Corresponding author
- Wang, Shizhen Emily
- ORCID
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2014-04
- Volume
- 25
- Issue
- 4
- Pages
- 501-515
- ISSN
- 1535-6108 (ISSN-L)
- PMC
- PMC4016197
- OpenAlex
- W2143839116
- Cited by
- 1,476
- References
- 62
- Citations by year
- 2026: 61 · 2025: 91 · 2024: 113 · 2023: 145 · 2022: 164 · 2021: 175 · 2020: 148 · 2019: 152 · 2018: 118 · 2017: 111 · 2016: 97 · 2015: 72 · 2014: 28
- FWCI
- 32.89
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cancer Cell (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- American Association for Cancer Research
- Breast Cancer Research Foundation (12-60-26-WANG)
- Celgene
- National Institutes of Health
- National Key Research and Development Program of China (2012CB9333004)
- National Cancer Institute (P30CA-33572, R01CA166020, R01CA163586, P30CA033572)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Keywords
- miR-105, metastasis, breast cancer, ZO-1, tight junctions, endothelial barrier integrity, exosomes, vascular permeability, metastatic progression
- MeSH terms
- Breast Neoplasms, Cell Movement, Endothelium, Vascular, Female, Humans, Neoplasm Metastasis, Biomarkers, Tumor, MicroRNAs, Cell Line, Tumor, Cell Growth Processes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review